Julia Canestraro, OD, FAAO
Optometrist
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Primary Care and Ocular Disease
- Contact Lens and Glasses Fittings
- Diagnosis and Non-Surgical Management of Ocular Tumors
About Me
- Assistant Attending Optometrist
I am passionate about eye care. As an optometrist at Memorial Sloan Kettering Cancer Center (MSK), my goal is to provide optimal vision and eye comfort to people undergoing treatment for cancer.
In addition to fitting patients with glasses and contact lenses, I provide ocular surface rehabilitation through various medical and non-invasive methods. I have experience in the diagnosis and non-surgical management of ocular disease, including ocular tumors. I also specialize in eye issues caused by cancer and its treatment.
Read more
Our patients should be able to concentrate on their therapy and rehabilitation; it is my job to meet all their eye care needs so they can do just that. I make it a priority to ensure that my patients feel heard and spend the time necessary to understand their unique vision problems. I believe in taking an individualized approach to care as we discuss a treatment plan, together.
I graduated from the State University of New York (SUNY) College of Optometry as part of the Beta Sigma Kappa Honors Society. I also received both the GP Lens Institute Clinical Excellence Award and the Dr. Louis Herrmann Memorial Award for Outstanding Compassion in Patient Care. From there, I continued my education with a residency in ocular disease at the SUNY College of Optometry.
I began my professional career as an assistant clinical professor at SUNY Optometry and went on to become the Assistant Director of Optometry at Woodhull Medical Center, where I served as the student externship supervisor and resident coordinator. After many fulfilling years as a clinician and clinical educator, my path has led to MSK, where I have the opportunity to put my skills to use at one of the preeminent hospitals in the nation. In 2022, I was awarded the SUNY Optometry Alumni Mentor of the Year.
In my spare time, I enjoy trying new restaurants and in the warmer months, hiking with my family and our dog.
An optometrist is a doctor with special training in eye diseases and vision problems. They also do routine eye exams.
My Specialties
- Primary Care and Ocular Disease
- Contact Lens and Glasses Fittings
- Diagnosis and Non-Surgical Management of Ocular Tumors
- Management of Ophthalmic Manifestations of Cancer
- Ocular Surface Rehabilitation
Education
- OD, SUNY College of Optometry
Residencies
- Ocular Disease - SUNY College of Optometry
Fellowships
- Fellow of the American Academy of Optometry
Board Certifications
- Diplomate of the American Board of Optometry
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Canestraro sees patients at one location.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
I have written a number of chapters in a clinical optometry textbook and have published numerous peer-reviewed papers (a few of these are highlighted below). Additionally, I have lectured for the American Academy of Optometry, as well as local Optometric Society meetings.
Read more
J Canestraro, Malin Hultcrantz, Shanu Modi, Paul A Hamlin, Alexander N Shoushtari, Jason A Konner, William P Tew, Neil M Iyengar, Murk Heinemann, David H Abramson, Jasmine H Francis. Refractive Shifts and Changes in Corneal Curvature Associated with Antibody-Drug Conjugates. Cornea. 2022,Jun;41(6):792-801.
Canestraro J, Do A, Potash SD, Panarelli J, Berkenstock M, Abramson DH, Francis JH. Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis). American Journal of Ophthalmology Case Reports. 2021,May;23:101125.
Canestraro J, Jaben KA, Wolchok JD, Abramson DA, Francis, JH. Progressive Choroidal Thinning (Leptochoroid) and Fundus Depigmentation Associated with Checkpoint Inhibitors. Journal of Ophthalmology Case Reports. 2020,Sep;19:1-4.
Visit PubMed for a full listing of Dr. Canestraro’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Julia Canestraro discloses the following relationships and financial interests:
-
Clarivate
Professional Services and Activities (Uncompensated) -
Immunogen
Professional Services and Activities (Uncompensated) -
New Jersey Society of Optometric Physicians
Professional Services and Activities
-
Professional Eye Care Associates of America
Professional Services and Activities -
Woo University
Professional Services and Activities (Uncompensated)
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].